Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
Go back to Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution| (NASDAQ: KNSA) | Delayed: 78.08 -1.72 (2.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.80 | 52 Week High | $ | |||
| Open | $79.60 | 52 Week Low | $ | |||
| Day High | $79.81 | P/E | N/A | |||
| Day Low | $77.71 | EPS | $ | |||
| Volume | 427,250 | |||||

